ISPOR workshop: What’s the evidence?

ISPOR South Africa cordially invites you to attend the first ISPOR SA Chapter Workshop for 2017.
Topic: “What’s the evidence?”- A practical approach on the HTA process in the UK: From the NICE appraisal to reimbursement
Date: 16 May 2017
Time: 08:45 – 15:00
Venue: Protea Hotel Marriot Balalaika, Maude Street, Sandown, Sandton
Faculty: Nan Oliver

Nan Oliver has worked as a health economist in the UK over the past eight years. While working for Novartis Oncology she was responsible for 13 health technology appraisals, including 6 submissions to NICE, 5 to the Scottish Medicines Consortium and 2 to the AWMSG in Wales. These submissions were for drugs used to treat various rare cancers and tumours in areas including chronic myeloid leukaemia, gastrointestinal stromal tumours, pancreatic neuroendocrine tumours, myelofibrosis and acromegaly. In her last year in the UK she was Head of Outcomes Research for Novartis Oncology.  She has a B Pharm degree from Rhodes, MBA from UCT and a post-graduate diploma in health economics (PGDip HE) from the University of York.  Having always worked in the pharmaceutical industry, Nan gained extensive experience in marketing, new product development and general management in South Africa before spending the last 14 years in the UK.   She initially worked in marketing In the UK but it soon became evident that market access was the key to achieving access for patients to appropriate treatments and so she retrained in health economics.

In the workshop, Nan will draw on her personal experience to highlight the processes and issues involved in making a submission to NICE, from planning the HTA strategy to developing the submission and managing the process through to final decision.   The workshop will be interactive with plenty of time for discussion and questions.

ISPOR SA chapter
Tel +27 (0)82 490 0478
E-mail [email protected]